Loading clinical trials...

Correlation of PET-CT Studies With Serum Protein Analysis | Clinical Trials | Clareo Health

COMPLETEDNCT00547742

Correlation of PET-CT Studies With Serum Protein Analysis

To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

NCT00349830 · Carcinomas (Including Squamous Cell and Adenocarcinoma), Neoplasms

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 20, 2010Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,500

Start dateJul 2005

Last updatedJul 20, 2010

Condition

Carcinomas (Including Squamous Cell and Adenocarcinoma)

Locations shown

Stanford University School of Medicine

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2010Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions